Which imaging modality is commonly used to evaluate suspected ovarian or adrenal tumors causing hyperandrogenism?

Which imaging modality is commonly used to evaluate suspected ovarian or adrenal tumors causing hyperandrogenism?

• A. Pelvic ultrasound
• B. CT abdomen-pelvis
• C. MRI brain
• D. X-ray pelvis

Answer: (B)

When a patient has hyperandrogenism and you’re worried about a tumor source, you need imaging that can assess both the ovaries and the adrenal glands in one study. CT of the abdomen and pelvis is typically used because it provides rapid, widely available, high-detail cross-sectional images of both regions. This allows you to localize an androgen-secreting ovarian tumor or an adrenal mass, assess their size and characteristics, and help with staging if needed. Pelvic ultrasound is excellent for evaluating ovarian anatomy, but it may miss adrenal pathology, and ultrasound isn’t as good at surveying both regions in one study. MRI offers excellent soft-tissue detail, especially for complex or indeterminate lesions, but it’s more resource-intensive and not as routinely used as the initial cross-sectional survey. X-ray pelvis lacks the soft-tissue detail needed to identify these tumors.

When a patient has hyperandrogenism and you’re worried about a tumor source, you need imaging that can assess both the ovaries and the adrenal glands in one study. CT of the abdomen and pelvis is typically used because it provides rapid, widely available, high-detail cross-sectional images of both regions. This allows you to localize an androgen-secreting ovarian tumor or an adrenal mass, assess their size and characteristics, and help with staging if needed.

Pelvic ultrasound is excellent for evaluating ovarian anatomy, but it may miss adrenal pathology, and ultrasound isn’t as good at surveying both regions in one study. MRI offers excellent soft-tissue detail, especially for complex or indeterminate lesions, but it’s more resource-intensive and not as routinely used as the initial cross-sectional survey. X-ray pelvis lacks the soft-tissue detail needed to identify these tumors.